Edward M Vital - Publications, H-index & Citations

Edward M Vital

university of leeds

42H指数

380论文数

1.1W被引数

收录论文 109

发表时间

Derivation, validation, and proposed thresholds of the Lupus Arthritis and Musculoskeletal Disease Activity (LAMDA) instrument: a cohort study 狼疮关节炎和肌肉骨骼疾病活动度（LAMDA）量表的推导、验证及推荐阈值：一项队列研究

Lancet Rheumatology

IF16.4

2026-09-02

OAAI

Samuel Wood; Khaled Mahmoud; Philip G Conaghan; Elizabeth M A Hensor; Edward M Vital

Long-Term Anifrolumab Treatment Normalizes Hematologic Parameters and Several Serologic Markers in Patients With Systemic Lupus Erythematosus 长期阿尼夫罗卢单抗治疗可改善系统性红斑狼疮患者的血液学参数和多种血清学标志物

ACR Open Rheumatology

IF2.8

2026-06-15

OAAI

Edward M. Vital; Zahir Amoura; Kenneth C. Kalunian; Ian N. Bruce; Yoshiya Tanaka; Susan Manzi; Ihor Hupka; Jacob Knagenhjelm; Hussein Al-Mossawi; Catharina Lindholm

Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus

New England Journal of Medicine

IF78.5

2026-03-01

PREAI

Furie, Richard A.; Dall'era, Maria; Vital, Edward M.; Garg, Jay P.; Irazoque Palazuelos, Fedra; Zuta Santillan, Adolfina E.; Ravelo-Hernandez, Jorge; Santiago, Mittermayer B.; Zazueta Montiel, Beatriz; Botha, Stella; Leszczynski, Piotr; de Souza, Viviane Angelina; Sicsik, Sandra A.; Bellatin, Luis; Naidoo, Asokan; Amoura, Zahir; D'Dgostino, Maria Antonietta; Kumar, Sunil; Workeneh, Biruh; Rae, Julie; Mao, Huiyan A.; Erblang, Felix; Meier, Oliver; Maller, Justine C.; Askanase, Anca D.

Low rate of infusion-related reactions and high treatment adherence with obinutuzumab in patients with active lupus nephritis: analysis of the NOBILITY and REGENCY studies 与输注相关的反应发生率低且奥比妥珠单抗治疗依从性高：NOBILITY和REGENCY研究的分析

Nephrology Dialysis Transplantation

IF5.6

2025-10-01

OAAI

Jones, Rachel B.; Rovin, Brad; Sehgal, Himanshi; Kirchner, Petra; Yoo, Bongin; Hassan, Imran; Schindler, Thomas; Martins, Elsa; Pendergraft, William F.; Garg, Jay; Vital, Edward; Lightstone, Liz

Late-Onset Spondylarthritis Presenting as Glucocorticoid-Resistant Polymyalgia Rheumatica: A hitherto underappreciated entity where TNF or IL-17 Blockade may have a Therapeutic Role 迟发性脊柱关节炎表现为糖皮质激素抵抗性风湿性多肌痛：一种迄今未受重视的实体，其中TNF或IL-17阻断剂可能具有治疗作用

Arthritis & Rheumatology

IF10.9

2025-07-22

OAAI

Kerem Abacar; Gabriele De Marco; Jake Weddell; Katya Meridor; Tom Macleod; Andrew Scarsbrook; Kulveer Mankia; Edward Vital; Andrew Barr; Colin Pease; Helena Marzo-Ortega; Sarah L. Mackie; Dennis McGonagle

ERN ReCONNET–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations ERN ReCONNET–SLICC–SLEuro专家共识：罕见系统性红斑狼疮表现的药物治疗管理

lancet rheumatology

IF0

2025-05-23

PREAI

Laurent Arnaud; Guillermo Ruiz-Irastorza; Cynthia Aranow; Sasha Bernatsky; Maria Dall'Era; Olufemi Adelowo; Sang-Cheol Bae; Lorenzo Beretta; Eloisa Bonfa; Ricard Cervera; François Chasset; Ann E Clarke; Nathalie Costedoat-Chalumeau; Andrea Doria; Gerard Espinosa; Antonis Fanouriakis; Micaela Fredi; Mariele Gatto; Dafna D Gladman; José A Gomez-Puerta; Murat Inanç; Luís S Ines; David Isenberg; Shinji Izuka; Nikita Khmelinskii; Alexandra Legge; Carla Macieira; Odirlei Andre Monticielo; Eric F Morand; Roberto Muñoz-Louis; Ivan Padjen; Michelle Petri; Matteo Piga; Bernardo A Pons-Estel; Giuseppe A Ramirez; Rosalind Ramsey-Goldman; Christophe Richez; Savino Sciascia; Carlos Enrique Toro-Gutierrez; Ronald F Van Vollenhoven; Edward M Vital; Maria Gerosa; Zahi Touma; Marta Mosca; Chiara Tani

Evaluating the concordance between BICLA and SRI4 in patients with systemic lupus erythematosus from the placebo arms of the EXPLORER and ATHOS trials 评估系统性红斑狼疮患者中BICLA与SRI4的一致性，这些患者来自EXPLORER和ATHOS试验的安慰剂组。

LUPUS SCIENCE & MEDICINE

IF3.5

2025-05-19

OAAI

Askanase, Anca D.; Vital, Edward M.; Meier, Oliver; Turchetta, Armando; Mao, Huiyan (Ashley); Maller, Justine; Terres, Jorge A. Ross; Dall'Era, Maria

End-stage renal failure in systemic lupus erythematosus may be explained by suboptimal care delivery to high-risk patient groups 系统性红斑狼疮的终末期肾衰竭可能是由对高风险患者群体的护理提供不足所致。

RHEUMATOLOGY

IF4.4

2025-04-28

PREAI

Bachvarova, Hristina; Thompson, Olivia; Md Yusof, Md Yuzaiful; Arnold, Jack; Dunn, Emma; Vital, Edward M.

Real-world use and outcomes of avacopan for ANCA-associated vasculitis differ from clinical trials and a historical cohort: a multicentre UK cohort study 真实世界中avacopan用于ANCA相关性血管炎的使用和结局与临床试验及历史队列存在差异：一项英国多中心队列研究

RHEUMATOLOGY

IF4.4

2025-04-28

PREAI

Wood, Samuel; Khan, Fahd A.; Aslam, Aamir; Mahmood, Farrouq; Ellis, Jessica; Skeoch, Sarah; Din, B. Naw Ra Aung; Tran, Gui; Reddy, Hanu; Bissell, Lesley-Anne; Freeston, Jane; Barr, Andrew; Ford, Helen; Morgan, Ann W.; Vital, Edward M.; Dunn, Emma; Dass, Shouvik; Dubey, Shirish; Bansal, Tarun; Heaney, Jonathan; Yusof, Md Yuzaiful Md

Discovery and validation of a new classification of ANA-RMDs that better predict long term outcomes compared to legacy diagnoses 发现和验证一种新的ANA-RMDs分类方法，该方法比传统诊断更能预测长期预后。

RHEUMATOLOGY

IF4.4

2025-04-28

PREAI

Arnold, Jack E.; Carter, Lucy Marie; Yusof, Md Yuzaiful Md; Wigston, Zoe; Toro-Dominguez, Daniel; Relton, Samuel; Barturen, Guillermo; Alarcon-Riquelme, Marta; Vital, Edward M.

Effectiveness and safety of rituximab and cyclophosphamide for the treatment of Sjögren's disease-related peripheral neuropathy: a retrospective cohort study 利妥昔单抗和环磷酰胺治疗舍格伦综合征相关周围神经病变的有效性与安全性：一项回顾性队列研究

RHEUMATOLOGY

IF4.4

2025-04-28

PREAI

Buss, Rihards; Vital, Edward M.; Davey, Richard; Emery, Paul; Md Yusof, Md Yuzaiful

Opportunities and limitations of B cell depletion approaches in SLE B细胞清除方法在SLE中的机遇与局限

NATURE REVIEWS RHEUMATOLOGY

IF32.7

2025-01-15

PREAI

Stockfelt, Marit; Teng, Y. K. Onno; Vital, Edward M.

ANIFROLUMAB FOR PATIENTS WITH MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS: INTERIM ANALYSIS OF A RETROSPECTIVE COHORT STUDY ANIFROLUMAB 用于中重度系统性红斑狼疮患者：一项回顾性队列研究的期中分析

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2024-06-01

PREAI

Vital, E. M.; Chasset, F.; Faria, R.; Carter, L. M.; Kielar, D.; Chen, S. Y.; Carty, L.; Natman, J.; Waratani., M.

PROTEOMIC ANALYSIS SUGGESTS ATWO-PHASE IMMUNE RESPONSE TO B CELL DEPLETION IN SYSTEMIC LUPUS ERYTHEMATOSUS 蛋白质组学分析表明，系统性红斑狼疮中B细胞耗竭会引起两阶段的免疫反应。

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2024-06-01

PREAI

Intapiboon, P.; Carter, L. M.; Arnold, J.; Mahmoud, K.; Yusof, M. Y. Md; Vital, E. M.

TWO-VARIABLE LUPUS ARTHRITIS AND MUSCULOSKELETAL DISEASE ACTIVITY SCORE (LAMDA2): A NOVEL TOOL TO MEASURE ARTHRITIS DISEASE ACTIVITY IN PEOPLE WITH SYSTEMIC LUPUS ERYTHEMATOSUS 双变量狼疮关节炎和肌肉骨骼疾病活动评分（LAMDA2）：一种用于测量系统性红斑狼疮患者关节炎疾病活动性的新工具

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2024-06-01

PREAI

Vital, E. M.; Hensor, E.; Mahmoud, K.

CONSENSUS-BASED RECOMMENDATIONS FOR GLUCOCORTICOID TAPERING IN SYSTEMIC LUPUS ERYTHEMATOSUS: RATIONALE AND DESIGN OF A MODIFIED DELPHI CONSENSUS PROJECT 基于共识的建议：系统性红斑狼疮中糖皮质激素减量的理据和改良德尔菲共识项目的设计

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2024-06-01

PREAI

Bertsias, G. K.; Vital, E. M.; Doria, A.; Johnson, S. R.; Mackie, S.; Pons-Estel, B.; Teng, Y. K. O.; Yazdany, J.; Navarra, S.

LONG-TERM OUTCOMES OF REPEAT CYCLES OF RITUXIMAB FOR SYSTEMIC MANIFESTATIONS OF SJOGREN'S DISEASE: MULTICENTRE UK COHORT STUDY 利妥昔单抗重复给药治疗干燥综合征系统性表现的长期结局：英国多中心队列研究

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2024-06-01

PREAI

Yusof, M. y. md; Berry, J.; Turtsevich, I.; Pepple, S.; Arnold, J.; Vital, E. M.; Gupta, M.; Bowman, S.; Ciurtin, C.; Fisher, B. A.; Ng, W. F.; Al-Obaidi, M.; Price, E.

EVALUATING THE CONCORDANCE BETWEEN SRI-4 AND BICLA IN THE EXPLORER AND ATHOS TRIALS IN ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS 评估EXPLORER和ATHOS试验中活动性系统性红斑狼疮患者SRI-4与BICLA的一致性

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2024-06-01

PREAI

Askanase, A.; Vital, E. M.; Meier, O.; Turchetta, A.; Mao, H. A.; Maller, J.; Terres, J. A. Ross; Dall'era, M.

LONGITUDINAL ASSESSMENT OF BIOMARKERS IN NOBILITY, A RANDOMIZED, PHASE II CLINICAL TRIAL OF OBINUTUZUMAB FOR TREATMENT OF PROLIFERATIVE LUPUS NEPHRITIS 纵向评估生物标志物在NOBILITY中的研究，这是一项关于奥滨尤妥珠单抗治疗增殖性狼疮肾炎的随机、二期临床试验。

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2024-06-01

PREAI

Vital, E. M.; Tas, S. W.; Malvar, A.; Looney, C. M.; Raghu, H.; Anania, V. G.; Mao, H. A.; Wang, T.; Williams, S.; Schindler, T.; Martins, E.; Terres, J. A. Ross; Pendergraft Iii, W. F.; Furie, R. A.

PERFORMANCE OF THE 2019 EULAR/ACR AND 2012 SLICC CLASSIFICATION CRITERIA FOR SLE AS DIAGNOSTIC CRITERIA 2019年EULAR/ACR和2012年SLICC分类标准在SLE诊断中的应用性能

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2024-06-01

PREAI

Crisafulli, F.; Yusof, M. Y. Md; Aslam, A.; Barr, A.; Bissell, L. A.; Dass, S.; Arnold, J.; Intapiboon, P.; Franceschini, F.; Vital, E. M.

研究方向